HOME › DRUGS › GALANTAMINE HYDROBROMIDE
ACTIVE SUBSTANCE / INN

GALANTAMINE HYDROBROMIDE

Brand name(s): RAZADYNE ER, GALANTAMINE HYDROBROMIDE, RAZADYNE
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
NDA021615
ANDA077592
ACTIVE SUBSTANCE
Galantamine Hydrobromide
REGULATORS
FDA
SPONSORS / MAH
JANSSEN PHARMS, HIKMA, SUN PHARM INDS
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
GALANTAMINE HYDROBROMIDEANDA077608HIKMADiscontinued
GALANTAMINE HYDROBROMIDEANDA078185HIKMAPrescription
GALANTAMINE HYDROBROMIDEANDA077592SUN PHARM INDSNone (Tentative Approval)
RAZADYNENDA021169JANSSEN PHARMSDiscontinued
RAZADYNE ERNDA021615JANSSEN PHARMSDiscontinued

FULL INTELLIGENCE ON GALANTAMINE HYDROBROMIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →